GlassScriptPhysician profile
George M Young
NPI 1245265677
$872.72
in general payments reported to CMS, 2019-2025
17 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $41.84 · 2021: $28.48 · 2022: $121 · 2023: $68.07 · 2024: $372 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $251.31 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Shield Therapeutics INC | $154.98 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $74.98 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $72.31 | 2021-2024 | Rybelsus, Ozempic |
| Noven Therapeutics, LLC | $48.61 | 2024 | Xelstrym |
| Abbott Laboratories | $43.69 | 2024-2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $43.10 | 2022-2024 | Quviviq |
| Alk-Abello, INC | $27.37 | 2024 | Grastek, Odactra, Ragwitek |
| Medtronic, INC. | $24.28 | 2024 | Intellis Adaptivestim |
| Supernus Pharmaceuticals, INC. | $24.13 | 2022 | |
| Becton, Dickinson and Company | $22.99 | 2022 | |
| Avanir Pharmaceuticals, INC. | $17.55 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $17.44 | 2025 | Rexulti |
| Exact Sciences Corporation | $16.69 | 2024 | Cologuard Collection Kit |
| Vivus LLC | $16.30 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $13.67 | 2022 | |
| Corium, LLC | $3.32 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.